NeuroPace Q1 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $18.124M Beat $17.302M Estimate
NeuroPace Q1 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $18.124M Beat $17.302M Estimate
NeuroPace 2024年第一季度GAAP每股收益美元（0.32）超過預期（0.33），銷售額爲1,8124萬美元，超過預期的1730.2萬美元
NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 21.95 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $18.124 million which beat the analyst consensus estimate of $17.302 million by 4.75 percent. This is a 25.23 percent increase over sales of $14.472 million the same period last year.
NeuroPace（納斯達克股票代碼：NPCE）公佈的季度虧損爲每股0.32美元，比分析師普遍預期的0.33美元（0.33美元）高出3.03個百分點。與去年同期每股虧損0.41美元（0.41美元）相比，增長了21.95％。該公司公佈的季度銷售額爲1812.4萬美元，比分析師普遍預期的1730.2萬美元高出4.75％。這比去年同期的14472萬美元的銷售額增長了25.23％。